跳至主要内容
临床试验/NCT05112640
NCT05112640终止不适用

Subcuticular Absorbable Staples Versus Conventional Skin Closure in Women Undergoing Cesarean Delivery: A Randomized Control Trial

The University of Texas Medical Branch, Galveston2 个研究点 分布在 1 个国家目标入组 117 人开始时间: 2021年11月16日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
117
试验地点
2
主要终点
Operating Time

研究概览

简要总结

Despite the high numbers of cesareans being performed, scientific evidence behind which surgical techniques are best remains uncertain. Our objective is to determine if subcuticular absorbable staples improve operative time and wound cosmetics.

详细描述

This will be an open-label randomized controlled clinical trial. Women undergoing cesarean delivery will be randomized to have either standard wound closure with Monocryl suture or absorbable subcuticular staples placed by INSORB skin stapling device. The INSORB under the skin stapling device is FDA approved but not currently used as standard of care at UTMB. We will exclude women with intraamniotic infection, immunosuppression, active skin infection, those unlikely to be followed-up after delivery, or unable to provide consent.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Outcomes Assessor)

盲法说明

Reviewers of wound cosmetics during the post operative time will be blind to the intervention. However, surgeon at the time skin closure and patient will not be blinded to the intervention.

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • 18-50 years of age
  • Women ≥ 24 weeks viable gestation
  • Will be undergoing cesarean delivery

排除标准

  • Patient unwilling or unable to provide consent.
  • No or very limited prenatal care or a non-resident patient who is unlikely to follow-up after delivery.
  • Immunosuppressed subjects: i.e., taking systemic immunosuppressant or steroids (e.g. transplant subjects; not including steroids for lung maturity), HIV with CD4 <200, or other
  • Decision not to have skin closure (e.g. secondary wound closure, mesh closure)
  • Current skin infection
  • Coagulopathy
  • High likelihood of additional surgical procedure beyond cesarean (e.g. scheduled hysterectomy, tubal ligation, bowel or adnexal surgery)
  • Incarcerated individuals
  • Intraamniotic infection
  • Subjects participating on other treatment trials or studies that would interfere with the current study's primary outcome.

结局指标

主要结局

Operating Time

时间窗: Start of surgery through end of skin closure in minutes

Total time for the procedure

次要结局

  • Use of Resources(Time of surgery through six weeks post partum)
  • Post Operative Pain(5-10 days)
  • Skin Closure Time in Minutes(Time of surgery through six weeks post partum)
  • Wound Cosmesis(Time of surgery through six weeks post partum)
  • Number of Adverse Events(Time of surgery through six weeks post partum)
  • Number of Participants With Composite Wound Complication(Time of surgery through six weeks post partum)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验